PMID: 9428794Jan 15, 1998Paper

A negative regulatory element and its binding protein in the upstream of enhancer II of hepatitis B virus

DNA and Cell Biology
G T ParkH M Rho

Abstract

The hepatitis B virus (HBV) core/pregenomic promoter is regulated by enhancer I (ENI) and enhancer II (ENII) which are located upstream of the initiation sites of core/pregenomic transcripts. In this study, we identified a negative regulatory element (NRE) (nt 1576 to 1639) upstream of ENII by serial deletion analysis; a 33 kDa cellular protein in HepG2 cells binds to this element. The NRE has a significant activity if it is located upstream of ENII in HepG2 cells. Mutational analysis showed that the sequence (5'-CCAC-3') from nt 1612 to 1615 is responsible for the repression activity of NRE. Southwestern blotting and UV-crosslinking assays with HepG2 nuclear extracts also demonstrated that the 33 kDa protein in HepG2 cells binds to the sequence. It, thus, appears that the 33 kDa protein is responsible for the repression activity of NRE.

References

Apr 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·H Su, J K Yee
Sep 1, 1992·The Journal of General Virology·S H KimH M Rho
Jul 1, 1992·Virology·K K Gerlach, R H Schloemer
Jan 1, 1992·The Journal of General Virology·D F Spandau, C H Lee
Jul 1, 1990·Molecular and Cellular Biology·R DiksteinY Shaul
Oct 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·W K MiskiminsF H Ruddle
Sep 1, 1982·Molecular and Cellular Biology·C M GormanB H Howard
Dec 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·J D LichtU Hansen
Oct 1, 1993·Virology·S T ChenJ K Yee
Aug 1, 1996·European Journal of Biochemistry·C Y CholH M Rho

❮ Previous
Next ❯

Citations

Sep 30, 2000·European Journal of Biochemistry·N JungI Bae
Sep 18, 2002·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Jin Ah Kwon, Hyune Mo Rho

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.